Related references
Note: Only part of the references are listed.Intratumoral immunotherapy relies on B and T cell collaboration
Idit Sagiv-Barfi et al.
SCIENCE IMMUNOLOGY (2022)
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Mohamad-Gabriel Alameh et al.
IMMUNITY (2021)
Ionizable lipid nanoparticles for in utero mRNA delivery
Rachel S. Riley et al.
SCIENCE ADVANCES (2021)
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity
Kimberly J. Hassett et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs
Melissa P. Lokugamage et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Antibodies against polyethylene glycol in human blood: A literature review
Lu Hong et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Asmita Pal et al.
FRONTIERS IN MICROBIOLOGY (2020)
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Gergely Tibor Kozma et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production
Takuya Suzuki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
Gal Cafri et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration
Lien Van Hoecke et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
Kimberly J. Hassett et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory
Christian Grunwitz et al.
ONCOIMMUNOLOGY (2019)
Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile
Rosa De Groot et al.
ONCOIMMUNOLOGY (2019)
The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles
Dongyu Chen et al.
NANOSCALE (2019)
B Cell-Based Cancer Immunotherapy
Kerstin Wennhold et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2019)
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety
Kevin Van der Jeught et al.
ACS NANO (2018)
A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated Liposomes
Taro Shimizu et al.
JOURNAL OF IMMUNOLOGY (2018)
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Matthias A. Oberli et al.
NANO LETTERS (2017)
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Suvasini Ramaswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Long-lasting multifunctional CD8+ T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination
Florian Wimmers et al.
ONCOIMMUNOLOGY (2016)
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
Sam Chen et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses
Ans De Beuckelaer et al.
MOLECULAR THERAPY (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines
Viswa Teja Colluru et al.
ONCOTARGET (2016)
Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon
Katrijn Broos et al.
Molecular Therapy-Nucleic Acids (2016)
mRNA vaccine delivery using lipid nanoparticles
Andreas M. Reichmuth et al.
THERAPEUTIC DELIVERY (2016)
Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells
Taro Shimizu et al.
IMMUNOBIOLOGY (2015)
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Norbert Pardi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
Kevin J. Kauffman et al.
NANO LETTERS (2015)
Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery
Hidetaka Akita et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery
Hidetaka Akita et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Acute and Chronic B Cell Depletion Disrupts CD4+ and CD8+ T Cell Homeostasis and Expansion during Acute Viral Infection in Mice
Jacquelyn M. Lykken et al.
JOURNAL OF IMMUNOLOGY (2014)
Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy
Varun Kumar et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment
Stefani Spranger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
Charlotte Pollard et al.
MOLECULAR THERAPY (2013)
CD40-Activated B Cells Can Efficiently Prime Antigen-Specific Naive CD8+ T Cells to Generate Effector but Not Memory T cells
Melissa Mathieu et al.
PLOS ONE (2012)
Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history
Patricia Fitzgerald-Bocarsly et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
Donatella Ciuffreda et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA
Aude Bonehill et al.
MOLECULAR THERAPY (2008)
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
Jorge R. Almeida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection
CC Bergmann et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
